Top

Journal of Cardiovascular Translational Research

Published in:

01-02-2022 | Myocardial Infarction | Review

Posttranslational Modifications: Emerging Prospects for Cardiac Regeneration Therapy

Authors: Ya-Fei Li, Ya-Xin Wang, Hao Wang, Yao Ma, Lian-Sheng Wang

Published in: Journal of Cardiovascular Translational Research | Issue 1/2022

Abstract

Heart failure (HF) following ischemic heart disease (IHD) remains a hard nut to crack and a leading cause of death worldwide. Cardiac regeneration aims to promote cardiomyocyte (CM) proliferation by transitioning the cell cycle state of CMs from arrest to re-entry. Protein posttranslational modifications (PTMs) have recently attracted extensive attention in the field of cardiac regeneration due to their reversibility and effects on the stability, activity, and subcellular localization of target proteins. The balance of PTMs is disrupted when neonatal CMs withdraw from the cell cycle, resulting in significant dysfunction of downstream substrate protein localization, expression, and activity, ultimately limiting the maintenance of cardiac regeneration ability. In this review, we summarize recent research concerning the role of PTMs in cardiac regeneration, while focusing on phosphorylation, acetylation, ubiquitination, glycosylation, methylation, and neddylation, and the effects of these modifications on CM proliferation, which may provide potential targets for future treatments for IHD.

Al’Aref, S. J., Anchouche, K., Singh, G., Slomka, P. J., Kolli, K. K., Kumar, A., et al. (2019). Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. European Heart Journal, 40(24), 1975–1986. https://doi.org/10.1093/eurheartj/ehy404.CrossRefPubMed

Cahill, T. J., Choudhury, R. P., & Riley, P. R. (2017). Heart regeneration and repair after myocardial infarction: Translational opportunities for novel therapeutics. Nature Reviews. Drug Discovery, 16(10), 699–717. https://doi.org/10.1038/nrd.2017.106.CrossRefPubMed

Marquis-Gravel, G., Moliterno, D. J., Francis, D. P., Juni, P., Rosenberg, Y. D., Claessen, B. E., et al. (2020). Improving the design of future PCI trials for stable coronary artery disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 76(4), 435–450. https://doi.org/10.1016/j.jacc.2020.05.060.CrossRefPubMed

Du, C., Fan, Y., Li, Y. F., Wei, T. W., & Wang, L. S. (2020). Research progress on myocardial regeneration: What is new? Chinese Medical Journal, (6), 716–723. https://doi.org/10.1097/CM9.0000000000000693.

Hashimoto, H., Olson, E. N., & Bassel-Duby, R. (2018). Therapeutic approaches for cardiac regeneration and repair. Nature Reviews. Cardiology, 15(10), 585–600. https://doi.org/10.1038/s41569-018-0036-6.CrossRefPubMedPubMedCentral

Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., et al. (2011). Transient regenerative potential of the neonatal mouse heart. Science, 331(6020), 1078–1080. https://doi.org/10.1126/science.1200708.CrossRefPubMedPubMedCentral

Mohamed, T. M. A., Ang, Y. S., Radzinsky, E., Zhou, P., Huang, Y., Elfenbein, A., et al. (2018). Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell, 173(1), 104–116 e112. https://doi.org/10.1016/j.cell.2018.02.014.CrossRefPubMedPubMedCentral

Chen, Y., Li, X., Li, B., Wang, H., Li, M., Huang, S., et al. (2019). Long non-coding RNA ECRAR triggers post-natal myocardial regeneration by activating ERK1/2 signaling. Molecular Therapy, 27(1), 29–45. https://doi.org/10.1016/j.ymthe.2018.10.021.CrossRefPubMed

Perrotta, F., Perna, A., Komici, K., Nigro, E., Mollica, M., D'Agnano, V., et al. (2020). The State of art of regenerative therapy in cardiovascular ischemic disease: Biology, signaling pathways, and epigenetics of endothelial progenitor cells. Cells, 9(8). https://doi.org/10.3390/cells9081886.

10.

Nian, M., Lee, P., Khaper, N., & Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research, 94(12), 1543–1553. https://doi.org/10.1161/01.RES.0000130526.20854.fa.CrossRefPubMed

11.

Chen, L., Liu, S., & Tao, Y. (2020). Regulating tumor suppressor genes: Post-translational modifications. Signal Transduction and Targeted Therapy, 5(1), 90. https://doi.org/10.1038/s41392-020-0196-9.CrossRefPubMedPubMedCentral

12.

Singh, M., Bacolla, A., Chaudhary, S., Hunt, C. R., Pandita, S., Chauhan, R., et al. (2020). Histone acetyltransferase MOF orchestrates outcomes at the crossroad of oncogenesis, dna damage response, proliferation, and stem cell development. Molecular and Cellular Biology, 40(18). https://doi.org/10.1128/MCB.00232-20.

13.

Chen, X., Li, Y., Luo, J., & Hou, N. (2020). Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration. Frontiers in Physiology, 11, 389. https://doi.org/10.3389/fphys.2020.00389.CrossRefPubMedPubMedCentral

14.

Chang, C. W., Dalgliesh, A. J., Lopez, J. E., & Griffiths, L. G. (2016). Cardiac extracellular matrix proteomics: Challenges, techniques, and clinical implications. Proteomics. Clinical Applications, 10(1), 39–50. https://doi.org/10.1002/prca.201500030.CrossRefPubMed

15.

Fan, Y., Cheng, Y., Li, Y., Chen, B., Wang, Z., Wei, T., et al. (2020). Phosphoproteomic analysis of neonatal regenerative myocardium revealed important roles of checkpoint kinase 1 via activating mammalian target of rapamycin C1/ribosomal protein S6 kinase b-1 pathway. Circulation, 141(19), 1554–1569. https://doi.org/10.1161/CIRCULATIONAHA.119.040747.CrossRefPubMed

16.

Zhang, J., Zhang, X., Huang, H., & Ding, Y. (2020). A review on kinases phosphorylating the carboxyl-terminal domain of RNA polymerase II-biological functions and inhibitors. Bioorganic Chemistry, 104, 104318. https://doi.org/10.1016/j.bioorg.2020.104318.CrossRefPubMed

17.

Czuba, L. C., Hillgren, K. M., & Swaan, P. W. (2018). Post-translational modifications of transporters. Pharmacology & Therapeutics, 192, 88–99. https://doi.org/10.1016/j.pharmthera.2018.06.013.CrossRef

18.

Nishioka, T., Shohag, M. H., Amano, M., & Kaibuchi, K. (2015). Developing novel methods to search for substrates of protein kinases such as Rho-kinase. Biochimica et Biophysica Acta, 1854(10 Pt B), 1663–1666. https://doi.org/10.1016/j.bbapap.2015.03.001.CrossRefPubMed

19.

Shah, K., & Kim, H. (2019). The significant others: Global search for direct kinase substrates using chemical approaches. IUBMB Life, 71(6), 721–737. https://doi.org/10.1002/iub.2023.CrossRefPubMed

20.

Gao, J., Shao, K., Chen, X., Li, Z., Liu, Z., Yu, Z., et al. (2020). The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation. Journal of Molecular and Cellular Cardiology, 138, 49–58. https://doi.org/10.1016/j.yjmcc.2019.11.146.CrossRefPubMed

21.

D'Uva, G., Aharonov, A., Lauriola, M., Kain, D., Yahalom-Ronen, Y., Carvalho, S., et al. (2015). ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nature Cell Biology, 17(5), 627–638. https://doi.org/10.1038/ncb3149.CrossRefPubMed

22.

Aharonov, A., Shakked, A., Umansky, K. B., Savidor, A., Genzelinakh, A., Kain, D., et al. (2020). ERBB2 drives YAP activation and EMT-like processes during cardiac regeneration. Nature Cell Biology, 22(11), 1346–1356. https://doi.org/10.1038/s41556-020-00588-4.CrossRefPubMed

23.

Fang, Y., Gupta, V., Karra, R., Holdway, J. E., Kikuchi, K., & Poss, K. D. (2013). Translational profiling of cardiomyocytes identifies an early Jak1/Stat3 injury response required for zebrafish heart regeneration. Proceedings of the National Academy of Sciences of the United States of America, 110(33), 13416–13421. https://doi.org/10.1073/pnas.1309810110.CrossRefPubMedPubMedCentral

24.

O'Meara, C. C., Wamstad, J. A., Gladstone, R. A., Fomovsky, G. M., Butty, V. L., Shrikumar, A., et al. (2015). Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circulation Research, 116(5), 804–815. https://doi.org/10.1161/CIRCRESAHA.116.304269.CrossRefPubMed

25.

Wodsedalek, D. J., Paddock, S. J., Wan, T. C., Auchampach, J. A., Kenarsary, A., Tsaih, S. W., et al. (2019). IL-13 promotes in vivo neonatal cardiomyocyte cell cycle activity and heart regeneration. American Journal of Physiology. Heart and Circulatory Physiology, 316(1), H24–H34. https://doi.org/10.1152/ajpheart.00521.2018.CrossRefPubMed

26.

Matrone, G., Wilson, K. S., Maqsood, S., Mullins, J. J., Tucker, C. S., & Denvir, M. A. (2015). CDK9 and its repressor LARP7 modulate cardiomyocyte proliferation and response to injury in the zebrafish heart. Journal of Cell Science, 128(24), 4560–4571. https://doi.org/10.1242/jcs.175018.CrossRefPubMedPubMedCentral

27.

Beigi, F., Schmeckpeper, J., Pow-Anpongkul, P., Payne, J. A., Zhang, L., Zhang, Z., et al. (2013). C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway. Circulation Research, 113(4), 372–380. https://doi.org/10.1161/CIRCRESAHA.113.301075.CrossRefPubMed

28.

Lin, Z., Zhou, P., von Gise, A., Gu, F., Ma, Q., Chen, J., et al. (2015). Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circulation Research, 116(1), 35–45. https://doi.org/10.1161/CIRCRESAHA.115.304457.CrossRefPubMed

29.

Xiang, F. L., Guo, M., & Yutzey, K. E. (2016). Overexpression of Tbx20 in adult cardiomyocytes promotes proliferation and improves cardiac function after myocardial infarction. Circulation, 133(11), 1081–1092. https://doi.org/10.1161/CIRCULATIONAHA.115.019357.CrossRefPubMedPubMedCentral

30.

Wei, L., Zhou, Q., Tian, H., Su, Y., Fu, G. H., & Sun, T. (2020). Integrin beta3 promotes cardiomyocyte proliferation and attenuates hypoxia-induced apoptosis via regulating the PTEN/Akt/mTOR and ERK1/2 pathways. International Journal of Biological Sciences, 16(4), 644–654. https://doi.org/10.7150/ijbs.39414.CrossRefPubMedPubMedCentral

31.

Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2018). New insights into the role of mTOR signaling in the cardiovascular system. Circulation Research, 122(3), 489–505. https://doi.org/10.1161/CIRCRESAHA.117.311147.CrossRefPubMedPubMedCentral

32.

Woulfe, K. C., Gao, E., Lal, H., Harris, D., Fan, Q., Vagnozzi, R., et al. (2010). Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo. Circulation Research, 106(10), 1635–1645. https://doi.org/10.1161/CIRCRESAHA.109.211482.CrossRefPubMedPubMedCentral

33.

Chen, Z., Xie, J., Hao, H., Lin, H., Wang, L., Zhang, Y., et al. (2017). Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3beta/cyclin D1 signalling pathway. Cardiovascular Research, 113(6), 620–632. https://doi.org/10.1093/cvr/cvx001.CrossRefPubMedPubMedCentral

34.

Wang, J., Liu, S., Heallen, T., & Martin, J. F. (2018). The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration. Nature Reviews. Cardiology, 15(11), 672–684. https://doi.org/10.1038/s41569-018-0063-3.CrossRefPubMed

35.

Xin, M., Kim, Y., Sutherland, L. B., Murakami, M., Qi, X., McAnally, J., et al. (2013). Hippo pathway effector Yap promotes cardiac regeneration. Proceedings of the National Academy of Sciences of the United States of America, 110(34), 13839–13844. https://doi.org/10.1073/pnas.1313192110.CrossRefPubMedPubMedCentral

36.

Lin, Z., Guo, H., Cao, Y., Zohrabian, S., Zhou, P., Ma, Q., et al. (2016). Acetylation of VGLL4 regulates Hippo-YAP signaling and postnatal cardiac growth. Developmental Cell, 39(4), 466–479. https://doi.org/10.1016/j.devcel.2016.09.005.CrossRefPubMedPubMedCentral

37.

Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., et al. (2005). p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes & Development, 19(10), 1175–1187. https://doi.org/10.1101/gad.1306705.CrossRef

38.

Newby, L. K., Marber, M. S., Melloni, C., Sarov-Blat, L., Aberle, L. H., Aylward, P. E., et al. (2014). Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial. Lancet, 384(9949), 1187–1195. https://doi.org/10.1016/S0140-6736(14)60417-7.CrossRefPubMed

39.

Huang, S., Li, X., Zheng, H., Si, X., Li, B., Wei, G., et al. (2019). Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation, 139(25), 2857–2876. https://doi.org/10.1161/CIRCULATIONAHA.118.038361.CrossRefPubMedPubMedCentral

40.

Moya, I. M., & Halder, G. (2016). The Hippo pathway in cellular reprogramming and regeneration of different organs. Current Opinion in Cell Biology, 43, 62–68. https://doi.org/10.1016/j.ceb.2016.08.004.CrossRefPubMed

41.

Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., et al. (2011). Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science, 332(6028), 458–461. https://doi.org/10.1126/science.1199010.CrossRefPubMedPubMedCentral

42.

Morikawa, Y., Heallen, T., Leach, J., Xiao, Y., & Martin, J. F. (2017). Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation. Nature, 547(7662), 227–231. https://doi.org/10.1038/nature22979.CrossRefPubMedPubMedCentral

43.

Nakamura, M., Zhai, P., Del Re, D. P., Maejima, Y., & Sadoshima, J. (2016). Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. JCI Insight, 1(5). https://doi.org/10.1172/jci.insight.86217.

44.

Deng, S., & Marmorstein, R. (2020). Protein N-Terminal acetylation: Structural basis, mechanism, versatility, and regulation. Trends in Biochemical Sciences. https://doi.org/10.1016/j.tibs.2020.08.005.

45.

Gong, F., & Miller, K. M. (2013). Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation. Mutation Research, 750(1-2), 23–30. https://doi.org/10.1016/j.mrfmmm.2013.07.002.CrossRefPubMed

46.

Shen, Y., Wei, W., & Zhou, D. X. (2015). Histone acetylation enzymes coordinate metabolism and gene expression. Trends in Plant Science, 20(10), 614–621. https://doi.org/10.1016/j.tplants.2015.07.005.CrossRefPubMed

47.

Saha, R. N., & Pahan, K. (2006). HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death and Differentiation, 13(4), 539–550. https://doi.org/10.1038/sj.cdd.4401769.CrossRefPubMed

48.

Yu, W., Ma, X., Xu, J., Heumuller, A. W., Fei, Z., Feng, X., et al. (2019). VGLL4 plays a critical role in heart valve development and homeostasis. PLoS Genetics, 15(2), e1007977. https://doi.org/10.1371/journal.pgen.1007977.CrossRefPubMedPubMedCentral

49.

Koontz, L. M., Liu-Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., et al. (2013). The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Developmental Cell, 25(4), 388–401. https://doi.org/10.1016/j.devcel.2013.04.021.CrossRefPubMedPubMedCentral

50.

de la Pompa, J. L., & Epstein, J. A. (2012). Coordinating tissue interactions: Notch signaling in cardiac development and disease. Developmental Cell, 22(2), 244–254. https://doi.org/10.1016/j.devcel.2012.01.014.CrossRefPubMedPubMedCentral

51.

MacGrogan, D., Munch, J., & de la Pompa, J. L. (2018). Notch and interacting signalling pathways in cardiac development, disease, and regeneration. Nature Reviews. Cardiology, 15(11), 685–704. https://doi.org/10.1038/s41569-018-0100-2.CrossRefPubMed

52.

Campa, V. M., Gutierrez-Lanza, R., Cerignoli, F., Diaz-Trelles, R., Nelson, B., Tsuji, T., et al. (2008). Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. The Journal of Cell Biology, 183(1), 129–141. https://doi.org/10.1083/jcb.200806104.CrossRefPubMedPubMedCentral

53.

Oie, E., Sandberg, W. J., Ahmed, M. S., Yndestad, A., Laerum, O. D., Attramadal, H., et al. (2010). Activation of Notch signaling in cardiomyocytes during post-infarction remodeling. Scandinavian Cardiovascular Journal, 44(6), 359–366. https://doi.org/10.3109/14017431.2010.511256.CrossRefPubMed

54.

Collesi, C., Felician, G., Secco, I., Gutierrez, M. I., Martelletti, E., Ali, H., et al. (2018). Reversible Notch1 acetylation tunes proliferative signalling in cardiomyocytes. Cardiovascular Research, 114(1), 103–122. https://doi.org/10.1093/cvr/cvx228.CrossRefPubMed

55.

Si, X., Zheng, H., Wei, G., Li, M., Li, W., Wang, H., et al. (2020). circRNA Hipk3 induces cardiac regeneration after myocardial infarction in mice by binding to Notch1 and miR-133a. Molecular Therapy--Nucleic Acids, 21, 636–655. https://doi.org/10.1016/j.omtn.2020.06.024.CrossRefPubMedPubMedCentral

56.

Collesi, C., Zentilin, L., Sinagra, G., & Giacca, M. (2008). Notch1 signaling stimulates proliferation of immature cardiomyocytes. The Journal of Cell Biology, 183(1), 117–128. https://doi.org/10.1083/jcb.200806091.CrossRefPubMedPubMedCentral

57.

Solomon, J. M., Pasupuleti, R., Xu, L., McDonagh, T., Curtis, R., DiStefano, P. S., et al. (2006). Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Molecular and Cellular Biology, 26(1), 28–38. https://doi.org/10.1128/MCB.26.1.28-38.2006.CrossRefPubMedPubMedCentral

58.

Haberland, M., Montgomery, R. L., & Olson, E. N. (2009). The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nature Reviews. Genetics, 10(1), 32–42. https://doi.org/10.1038/nrg2485.CrossRefPubMedPubMedCentral

59.

Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., et al. (2007). Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nature Medicine, 13(3), 324–331. https://doi.org/10.1038/nm1552.CrossRefPubMed

60.

Kook, H., & Epstein, J. A. (2003). Hopping to the beat. Hop regulation of cardiac gene expression. Trends in Cardiovascular Medicine, 13(7), 261–264. https://doi.org/10.1016/s1050-1738(03)00107-5.CrossRefPubMed

61.

Muhlfriedel, S., Kirsch, F., Gruss, P., Stoykova, A., & Chowdhury, K. (2005). A roof plate-dependent enhancer controls the expression of Homeodomain only protein in the developing cerebral cortex. Developmental Biology, 283(2), 522–534. https://doi.org/10.1016/j.ydbio.2005.04.033.CrossRefPubMed

62.

Trivedi, C. M., Zhu, W., Wang, Q., Jia, C., Kee, H. J., Li, L., et al. (2010). Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Developmental Cell, 19(3), 450–459. https://doi.org/10.1016/j.devcel.2010.08.012.CrossRefPubMedPubMedCentral

63.

Palacios, J. A., Herranz, D., De Bonis, M. L., Velasco, S., Serrano, M., & Blasco, M. A. (2010). SIRT1 contributes to telomere maintenance and augments global homologous recombination. The Journal of Cell Biology, 191(7), 1299–1313. https://doi.org/10.1083/jcb.201005160.CrossRefPubMedPubMedCentral

64.

Wu, Y., Zhou, L., Liu, H., Duan, R., Zhou, H., Zhang, F., et al. (2020). LRP6 downregulation promotes cardiomyocyte proliferation and heart regeneration. Cell Research. https://doi.org/10.1038/s41422-020-00411-7.

65.

Li, B., Li, M., Li, X., Li, H., Lai, Y., Huang, S., et al. (2019). Sirt1-inducible deacetylation of p21 promotes cardiomyocyte proliferation. Aging (Albany NY), 11(24), 12546–12567. https://doi.org/10.18632/aging.102587.CrossRef

66.

Willis, M. S., Townley-Tilson, W. H., Kang, E. Y., Homeister, J. W., & Patterson, C. (2010). Sent to destroy: The ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circulation Research, 106(3), 463–478. https://doi.org/10.1161/CIRCRESAHA.109.208801.CrossRefPubMedPubMedCentral

67.

Hedhli, N., & Depre, C. (2010). Proteasome inhibitors and cardiac cell growth. Cardiovascular Research, 85(2), 321–329. https://doi.org/10.1093/cvr/cvp226.CrossRefPubMed

68.

Hosseini, S. M., Okoye, I., Chaleshtari, M. G., Hazhirkarzar, B., Mohamadnejad, J., Azizi, G., et al. (2019). E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions. Clinica Chimica Acta, 498, 126–134. https://doi.org/10.1016/j.cca.2019.08.020.CrossRef

69.

Liu, L., Wong, C. C., Gong, B., & Yu, J. (2018). Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer. Oncogene, 37(2), 148–159. https://doi.org/10.1038/onc.2017.313.CrossRefPubMed

70.

Dang, F., Nie, L., & Wei, W. (2020). Ubiquitin signaling in cell cycle control and tumorigenesis. Cell Death and Differentiation. https://doi.org/10.1038/s41418-020-00648-0.

71.

Tamamori-Adachi, M., Hayashida, K., Nobori, K., Omizu, C., Yamada, K., Sakamoto, N., et al. (2004). Down-regulation of p27Kip1 promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin D1 and CDK4. Evidence for impaired Skp2-dependent degradation of p27 in terminal differentiation. The Journal of Biological Chemistry, 279(48), 50429–50436. https://doi.org/10.1074/jbc.M403084200.CrossRefPubMed

72.

Zou, J., Ma, W., Li, J., Littlejohn, R., Zhou, H., Kim, I. M., et al. (2018). Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. Proceedings of the National Academy of Sciences of the United States of America, 115(17), E4101–E4110. https://doi.org/10.1073/pnas.1719309115.CrossRefPubMedPubMedCentral

73.

Torrini, C., Cubero, R. J., Dirkx, E., Braga, L., Ali, H., Prosdocimo, G., et al. (2019). Common regulatory pathways mediate activity of microRNAs inducing cardiomyocyte proliferation. Cell Reports, 27(9), 2759–2771 e2755. https://doi.org/10.1016/j.celrep.2019.05.005.CrossRefPubMed

74.

Dong, W., Xie, F., Chen, X. Y., Huang, W. L., Zhang, Y. Z., Luo, W. B., et al. (2019). Inhibition of Smurf2 translation by miR-322/503 protects from ischemia-reperfusion injury by modulating EZH2/Akt/GSK3beta signaling. American Journal of Physiology. Cell Physiology, 317(2), C253–C261. https://doi.org/10.1152/ajpcell.00375.2018.CrossRefPubMed

75.

Ghosh, R., Vinod, V., Symons, J. D., & Boudina, S. (2020). Protein and mitochondria quality control mechanisms and cardiac aging. Cells, 9(4). https://doi.org/10.3390/cells9040933.

76.

Thomas, D. R., & Scott, N. E. (2020). Glycoproteomics: Growing up fast. Current Opinion in Structural Biology, 68, 18–25. https://doi.org/10.1016/j.sbi.2020.10.028.CrossRefPubMed

77.

Peanne, R., de Lonlay, P., Foulquier, F., Kornak, U., Lefeber, D. J., Morava, E., et al. (2018). Congenital disorders of glycosylation (CDG): Quo vadis? European Journal of Medical Genetics, 61(11), 643–663. https://doi.org/10.1016/j.ejmg.2017.10.012.CrossRefPubMed

78.

Bassat, E., Mutlak, Y. E., Genzelinakh, A., Shadrin, I. Y., Baruch Umansky, K., Yifa, O., et al. (2017). The extracellular matrix protein agrin promotes heart regeneration in mice. Nature, 547(7662), 179–184. https://doi.org/10.1038/nature22978.CrossRefPubMedPubMedCentral

79.

Kuhn, B., del Monte, F., Hajjar, R. J., Chang, Y. S., Lebeche, D., Arab, S., et al. (2007). Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nature Medicine, 13(8), 962–969. https://doi.org/10.1038/nm1619.CrossRefPubMed

80.

Magadum, A., Singh, N., Kurian, A. A., Sharkar, M. T. K., Chepurko, E., & Zangi, L. (2018). Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration. Molecular Therapy--Nucleic Acids, 13, 133–143. https://doi.org/10.1016/j.omtn.2018.08.021.CrossRefPubMedPubMedCentral

81.

Contessotto, P., Ellis, B. W., Jin, C., Karlsson, N. G., Zorlutuna, P., Kilcoyne, M., et al. (2020). Distinct glycosylation in membrane proteins within neonatal versus adult myocardial tissue. Matrix Biology, 85-86, 173–188. https://doi.org/10.1016/j.matbio.2019.05.001.CrossRefPubMed

82.

Wang, J., & Wang, G. G. (2020). No easy way out for EZH2: Its pleiotropic, noncanonical effects on gene regulation and cellular function. International Journal of Molecular Sciences, 21(24). https://doi.org/10.3390/ijms21249501.

83.

Chen, Y., Ren, B., Yang, J., Wang, H., Yang, G., Xu, R., et al. (2020). The role of histone methylation in the development of digestive cancers: a potential direction for cancer management. Signal Transduction and Targeted Therapy, 5(1), 143. https://doi.org/10.1038/s41392-020-00252-1.CrossRefPubMedPubMedCentral

84.

Ben-Yair, R., Butty, V. L., Busby, M., Qiu, Y., Levine, S. S., Goren, A., et al. (2019). H3K27me3-mediated silencing of structural genes is required for zebrafish heart regeneration. Development, 146(19). https://doi.org/10.1242/dev.178632.

85.

Meng, T. G., Zhou, Q., Ma, X. S., Liu, X. Y., Meng, Q. R., Huang, X. J., et al. (2020). PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome. Nature Communications, 11(1), 6354. https://doi.org/10.1038/s41467-020-20242-9.CrossRefPubMedPubMedCentral

86.

Ai, S., Yu, X., Li, Y., Peng, Y., Li, C., Yue, Y., et al. (2017). Divergent requirements for EZH1 in heart development versus regeneration. Circulation Research, 121(2), 106–112. https://doi.org/10.1161/CIRCRESAHA.117.311212.CrossRefPubMedPubMedCentral

87.

Paige, S. L., Thomas, S., Stoick-Cooper, C. L., Wang, H., Maves, L., Sandstrom, R., et al. (2012). A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell, 151(1), 221–232. https://doi.org/10.1016/j.cell.2012.08.027.CrossRefPubMedPubMedCentral

88.

Zhao, W., Liu, L., Pan, B., Xu, Y., Zhu, J., Nan, C., et al. (2015). Epigenetic regulation of cardiac myofibril gene expression during heart development. Cardiovascular Toxicology, 15(3), 203–209. https://doi.org/10.1007/s12012-014-9278-7.CrossRefPubMed

89.

Stein, A. B., Jones, T. A., Herron, T. J., Patel, S. R., Day, S. M., Noujaim, S. F., et al. (2011). Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. The Journal of Clinical Investigation, 121(7), 2641–2650. https://doi.org/10.1172/JCI44641.CrossRefPubMedPubMedCentral

90.

Kamitani, T., Kito, K., Fukuda-Kamitani, T., & Yeh, E. T. (2001). Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. The Journal of Biological Chemistry, 276(49), 46655–46660. https://doi.org/10.1074/jbc.M108636200.CrossRefPubMed

91.

Sarikas, A., Hartmann, T., & Pan, Z. Q. (2011). The cullin protein family. Genome Biology, 12(4), 220. https://doi.org/10.1186/gb-2011-12-4-220.CrossRefPubMedPubMedCentral

92.

Kook, H., Seo, S. B., & Jain, R. (2017). EZ Switch From EZH2 to EZH1: Histone methylation opens a window of cardiac regeneration. Circulation Research, 121(2), 91–94. https://doi.org/10.1161/CIRCRESAHA.117.311351.CrossRefPubMed

Title: Posttranslational Modifications: Emerging Prospects for Cardiac Regeneration Therapy
Authors: Ya-Fei Li
Ya-Xin Wang
Hao Wang
Yao Ma
Lian-Sheng Wang
Publication date: 01-02-2022
Publisher: Springer US
Keywords: Myocardial Infarction
Heart Failure
Published in: Journal of Cardiovascular Translational Research / Issue 1/2022
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-021-10135-7

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Posttranslational Modifications: Emerging Prospects for Cardiac Regeneration Therapy

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

A Translational ‘Humanised’ Porcine Model for Trans-Septal Mitral Valve Interventions: the Right Pulmonary Vein Approach

Sacubitril/Valsartan Decreases Atrial Fibrillation Susceptibility by Inhibiting Angiotensin II-Induced Atrial Fibrosis Through p-Smad2/3, p-JNK, and p-p38 Signaling Pathways

Cardiopulmonary Exercise Testing with Echocardiography to Identify Mechanisms of Unexplained Dyspnea

Letter to the Editor

Key Roles of RGD-Recognizing Integrins During Cardiac Development, on Cardiac Cells, and After Myocardial Infarction

Renal Revascularization Attenuates Myocardial Mitochondrial Damage and Improves Diastolic Function in Pigs with Metabolic Syndrome and Renovascular Hypertension

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page